Literature DB >> 27449718

Routine Postoperative Laboratory Tests Are Unnecessary After Partial Knee Arthroplasty.

Julie L Shaner1, Ammar R Karim2, David S Casper1, Christopher J Ball1, Eric M Padegimas1, Jess H Lonner3.   

Abstract

BACKGROUND: While partial knee arthroplasty (PKA) is increasingly performed on an outpatient basis, many surgeons still admit patients overnight and obtain laboratory studies on the first postoperative day. The purpose of this study was to investigate the utility and cost effectiveness of routine postoperative laboratory studies after PKA.
METHODS: This is a retrospective review of 322 consecutive unilateral or bilateral simultaneous PKAs (unicompartmental, patellofemoral, and modular bicompartmental knee arthroplasty) performed by a single surgeon. There were 408 complete blood counts and basic metabolic panels ordered.
RESULTS: Despite a large number of laboratory studies ordered and abnormalities detected, there was a 1.6% rate of laboratory-associated interventions (for either hypokalemia or hyperglycemia in 5 patients) and no red blood cell transfusions. Hospital charges associated with laboratory studies totaled $85,413. There were no 90-day postoperative hospital readmissions or emergency department evaluations related to abnormal postoperative laboratory values.
CONCLUSION: With an increasing emphasis placed on cost containment, the low rate of laboratory-associated interventions after PKA suggests that routinely obtaining laboratory studies are neither necessary nor cost effective.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Medicare charges; bicompartmental; laboratory studies; partial knee arthroplasty; patellofemoral; unicompartmental

Mesh:

Year:  2016        PMID: 27449718     DOI: 10.1016/j.arth.2016.05.052

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  7 in total

1.  Utility of Postoperative Serial Renal Function Monitoring in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma.

Authors:  Christopher Bitcon; Stewart Whalen; Jenna Coleman; Ricardo Rendon; Greg Bailly; David Bell; Ashley Cox; Jon Duplisea; Karthik Tenankore; Ross Mason
Journal:  Ann Surg Oncol       Date:  2022-04-05       Impact factor: 5.344

2.  The role of routine laboratory tests after unilateral total knee arthroplasty.

Authors:  An-An Li; Yu Zhang; Hao Zhang; Mei-Ying Yan; Shi-Ning Xiao; Nan-Shan Zhong; Xin-Hua Long; Shi-Jiang Wang; Yang Zhou
Journal:  BMC Musculoskelet Disord       Date:  2022-06-10       Impact factor: 2.562

3.  The necessity of routine postoperative laboratory tests in enhanced recovery after surgery for primary hip and knee arthroplasty: A retrospective cohort study protocol.

Authors:  Xiang-Dong Wu; Peng-Cheng Xiao; Zheng-Lin Zhu; Jia-Cheng Liu; Yu-Jian Li; Wei Huang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Usefulness of Perioperative Laboratory Tests in Total Hip and Knee Arthroplasty: Are They Necessary for All Patients?

Authors:  Marc R Angerame; David C Holst; Alexandria Phocas; Michael A Williams; Douglas A Dennis; Jason M Jennings
Journal:  Arthroplast Today       Date:  2021-01-30

5.  Utility of postoperative hemoglobin testing following total shoulder arthroplasty.

Authors:  Elshaday S Belay; Etienne Flamant; Barrie Sugarman; Daniel E Goltz; Christopher S Klifto; Oke Anakwenze
Journal:  JSES Int       Date:  2020-09-08

6.  The role of routine postoperative laboratory tests following hip hemiarthroplasty for an elderly femoral neck fracture.

Authors:  Teng-Feng Zhuang; Song-Wei Huan; Si-Min Luo; Guo-Rong She; Wen-Rui Wu; Jun-Yuan Chen; Ning Liu; Zhen-Gang Zha
Journal:  BMC Musculoskelet Disord       Date:  2021-09-18       Impact factor: 2.362

7.  The necessity of routine postoperative laboratory tests after total hip arthroplasty for hip fracture in a semi-urgent clinical setting.

Authors:  Xiang-Dong Wu; Jia-Cheng Liu; Yu-Jian Li; Jia-Wei Wang; Gui-Xing Qiu; Wei Huang
Journal:  J Orthop Traumatol       Date:  2020-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.